Profil
Dr. Nicholas M.
Dean is a Director & Chief Scientific Officer at Microlin Bio, Inc. He is on the Board of Directors at Microlin Bio, Inc.
Dr. Dean was previously employed as a Director & Chief Scientific Officer by Excaliard Pharmaceuticals, Inc. and Vice President-Functional Genomics & Oncology by Isis Pharmaceuticals, Inc.
He received his undergraduate degree from The University of Wales and a doctorate degree from The University of Wales.
Anciens postes connus de Nicholas M. Dean
| Sociétés | Poste | Fin |
|---|---|---|
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutics for the treatment of scarring & fibrotic disorders | Fondateur | 01/03/2012 |
Microlin Bio, Inc. /Old/
Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Operates as a pre-clinical stage biopharmaceutical company | Directeur Technique/Scientifique/R&D | - |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Nicholas M. Dean
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Microlin Bio, Inc. /Old/
Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Operates as a pre-clinical stage biopharmaceutical company | Health Technology |
The University of Wales
The University of Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutics for the treatment of scarring & fibrotic disorders | Health Technology |
















